Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

The Price to Operating Profit (P/OP) ratio for the observed period exhibits significant fluctuations, transitioning from periods of non-existence to substantial values and back again. Initial years demonstrate a lack of calculable P/OP ratios due to negative or zero operating profit per share. A notable shift occurs around 2012, with the ratio becoming positive and varying considerably in subsequent years.

Early Period (2006-2011)

From 2006 through 2011, the operating profit per share remained negative. Consequently, the P/OP ratio could not be meaningfully calculated during this timeframe. This indicates the company was not generating positive operating income attributable to each share outstanding.

Initial Positive Ratios (2012-2013)

The year 2012 marks the first instance of a positive operating profit per share, resulting in a P/OP ratio of 69.48. This is followed by a dramatic increase in 2013 to 4,319.80, suggesting a substantial increase in share price relative to operating profit. This could be indicative of heightened investor expectations or speculative trading.

Volatility and Decline (2014-2016)

The P/OP ratio experiences considerable volatility between 2014 and 2016. It is not calculated in 2014, then returns in 2016 at 2,143.58. This period suggests continued uncertainty regarding the company’s profitability and its impact on market valuation.

Stabilization and Reduction (2017-2021)

From 2017 to 2021, the P/OP ratio demonstrates a decreasing trend, moving from 331.55 to 19.16. This coincides with increasing operating profit per share, indicating that while the share price also increased, operating profit grew at a faster rate. This suggests a more reasonable valuation relative to earnings.

Recent Fluctuations (2022-2025)

The ratio fluctuates again in more recent years, with values of 22.35, 17.75, 28.74, and a return to a negative value in 2025 (-0.91). The negative value in 2025 indicates a loss in operating profit per share, leading to an undefined P/OP ratio. The final reported value in 2026 is 29.92, suggesting a recovery in operating profit.

Overall, the P/OP ratio demonstrates a complex pattern, initially hampered by negative operating profits, followed by periods of high volatility and, more recently, a trend towards stabilization before a final fluctuation. The significant swings in the ratio highlight the sensitivity of the valuation to changes in both share price and operating profitability.